Tag Archives: GlaxoSmithKline

GlaxoSmithKline settles case with woman who linked her use of antidepressant Paxil to the death of her infant son

A settlement has been reached in a lawsuit filed against a pharmaceutical company by a Watertown woman who linked her prescribed use of Paxil to the death of her infant son, according to court files. Jennifer Berg of Watertown sued SmithKline Beecham, doing business as GlaxoSmithKline, in October 2007. The complaint said Nathan Berg died in 2004 because of a heart disorder caused by her use of the antidepressant Paxil while she was pregnant.

Glaxo To Book $2.4 billion To Settle Legal Cases, Including Avandia, Paxil

British Pharma giant GlaxoSmithKline is expected to record a legal charge of $2.4 billion for the second quarter of this fiscal year in order to settle legal cases relating to its antidepressant Paxil and controversial diabetes pill Avandia. The British company announced two days ago that the money would be used not only to cover the settlements for Avandia but also other long-standing legal cases.

Heavy Doses—Drug Company J&J Pays Docs Millions for “speaking & consulting gigs”

Speaking and consulting gigs for drug companies can be lucrative for doctors. Birmingham, Alabama, psychiatrist James E. Parker was paid more than $21,000 in speaking fees between January and March by a Johnson & Johnson company that sells mental health drugs.

GlaxoSmithKline Enters into Confidential Settlement with 200 Families Who Say Paxil Caused Birth Defects

Pharmaceutical giant GlaxoSmithKline has entered into confidential settlements with nearly 200 families who claimed that its antidepressant Paxil caused congenital birth defects. Most of the claims alleged that babies born to mothers taking Paxil suffered heart defects.

Australian Psychiatrist Patrick McGorry Wants His Pre-Drugging Agenda to Go Global

“Australia is a place that can actually change the world in mental health, provided we get the right government support to do so.” — Patrick McGorry